Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 2, 1998

View Archived Issues

XTL Biopharmaceuticals Nets US$10M For Anti-HBV Compound

ReGen Raises £2.1M To Push Alzheimer's Drug To Market

BioTuL Aims At Big Market With Lower-Cost Biosensor

Debate Over Research Rules May Grow More Complicated

In Search For Cancer Vaccines, Pasteur Merieux's Network Adds Dalhousie Researchers

Prolifix, Biofocus Partner For Anticancer Molecules

Remicade Approval Triggers License Payment To Celltech